<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Miracle prostate cancer drug not so miraculous?</title>
	<atom:link href="http://gayathrivaidyanathan.com/2009/06/25/miracle-prostate-cancer-drug-not-so-miraculous/feed/" rel="self" type="application/rss+xml" />
	<link>http://gayathrivaidyanathan.com/2009/06/25/miracle-prostate-cancer-drug-not-so-miraculous/</link>
	<description>Journalist &#38; Multimedia Reporter</description>
	<lastBuildDate>Wed, 09 Jun 2010 03:03:01 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: BLOG: High expectations for melanoma drug ipilimumab &#8211; Gayathri Vaidyanathan ::</title>
		<link>http://gayathrivaidyanathan.com/2009/06/25/miracle-prostate-cancer-drug-not-so-miraculous/comment-page-1/#comment-80</link>
		<dc:creator>BLOG: High expectations for melanoma drug ipilimumab &#8211; Gayathri Vaidyanathan ::</dc:creator>
		<pubDate>Wed, 09 Jun 2010 03:03:01 +0000</pubDate>
		<guid isPermaLink="false">http://gayathrivaidyanathan.com/?p=97#comment-80</guid>
		<description>[...] I wrote about the cancer drug ipilimumab last year, which has been hailed as miraculous by some. The drug has been through Phase 3 clinical trials and results will be presented on June 6 at the annual meeting of the American Society of Clinical Oncology (ASCO). [...]</description>
		<content:encoded><![CDATA[<p>[...] I wrote about the cancer drug ipilimumab last year, which has been hailed as miraculous by some. The drug has been through Phase 3 clinical trials and results will be presented on June 6 at the annual meeting of the American Society of Clinical Oncology (ASCO). [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

